Cargando…

Autoantibody-dependent amplification of inflammation in SLE

Anti-double stranded DNA antibodies (anti-dsDNA) are a hallmark of SLE but their role in disease pathogenesis is not fully resolved. Anti-dsDNA in serum are highly heterogeneous therefore in this study, we aimed to dissect the functional specificities of anti-dsDNA using a panel of human monoclonal...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Hantao, Wojciak-Stothard, Beata, Ruseva, Marieta M., Cook, H. Terence, Kelleher, Peter, Pickering, Matthew C., Mongkolsapaya, Juthathip, Screaton, Gavin R., Xu, Xiao-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481301/
https://www.ncbi.nlm.nih.gov/pubmed/32908129
http://dx.doi.org/10.1038/s41419-020-02928-6
_version_ 1783580571841069056
author Lou, Hantao
Wojciak-Stothard, Beata
Ruseva, Marieta M.
Cook, H. Terence
Kelleher, Peter
Pickering, Matthew C.
Mongkolsapaya, Juthathip
Screaton, Gavin R.
Xu, Xiao-Ning
author_facet Lou, Hantao
Wojciak-Stothard, Beata
Ruseva, Marieta M.
Cook, H. Terence
Kelleher, Peter
Pickering, Matthew C.
Mongkolsapaya, Juthathip
Screaton, Gavin R.
Xu, Xiao-Ning
author_sort Lou, Hantao
collection PubMed
description Anti-double stranded DNA antibodies (anti-dsDNA) are a hallmark of SLE but their role in disease pathogenesis is not fully resolved. Anti-dsDNA in serum are highly heterogeneous therefore in this study, we aimed to dissect the functional specificities of anti-dsDNA using a panel of human monoclonal antibodies (humAbs) generated from patients with active lupus nephritis. A total of 46 ANA reactive humAbs were isolated and divided into four broad classes based on their reactivity to histones, DNA and Crithidia. Functional analysis indicated that one subclass of antibodies bound strongly to decondensed DNA areas in neutrophil extracellular traps (NETs) and protected NETs from nuclease digestion, similar to the sera from active SLE patients. In addition, these anti-dsDNA antibodies could stimulate type I interferon responses in mononuclear phagocytic cells, or NF-kB activity in endothelial cells, by uptake of NETs-anti-NETs immune complexes and subsequently trigging inflammatory responses in an Fc-gamma receptor (Fcg-R)-dependant manner. Together our data suggest that only a subset of anti-dsDNA antibodies is capable to amplify inflammatory responses by deposit in the nephritic kidney in vivo, protecting NETs digestion as well as uptake of NETs immune complexes into Fcg-R-expressing cells in vitro.
format Online
Article
Text
id pubmed-7481301
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-74813012020-09-21 Autoantibody-dependent amplification of inflammation in SLE Lou, Hantao Wojciak-Stothard, Beata Ruseva, Marieta M. Cook, H. Terence Kelleher, Peter Pickering, Matthew C. Mongkolsapaya, Juthathip Screaton, Gavin R. Xu, Xiao-Ning Cell Death Dis Article Anti-double stranded DNA antibodies (anti-dsDNA) are a hallmark of SLE but their role in disease pathogenesis is not fully resolved. Anti-dsDNA in serum are highly heterogeneous therefore in this study, we aimed to dissect the functional specificities of anti-dsDNA using a panel of human monoclonal antibodies (humAbs) generated from patients with active lupus nephritis. A total of 46 ANA reactive humAbs were isolated and divided into four broad classes based on their reactivity to histones, DNA and Crithidia. Functional analysis indicated that one subclass of antibodies bound strongly to decondensed DNA areas in neutrophil extracellular traps (NETs) and protected NETs from nuclease digestion, similar to the sera from active SLE patients. In addition, these anti-dsDNA antibodies could stimulate type I interferon responses in mononuclear phagocytic cells, or NF-kB activity in endothelial cells, by uptake of NETs-anti-NETs immune complexes and subsequently trigging inflammatory responses in an Fc-gamma receptor (Fcg-R)-dependant manner. Together our data suggest that only a subset of anti-dsDNA antibodies is capable to amplify inflammatory responses by deposit in the nephritic kidney in vivo, protecting NETs digestion as well as uptake of NETs immune complexes into Fcg-R-expressing cells in vitro. Nature Publishing Group UK 2020-09-09 /pmc/articles/PMC7481301/ /pubmed/32908129 http://dx.doi.org/10.1038/s41419-020-02928-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Lou, Hantao
Wojciak-Stothard, Beata
Ruseva, Marieta M.
Cook, H. Terence
Kelleher, Peter
Pickering, Matthew C.
Mongkolsapaya, Juthathip
Screaton, Gavin R.
Xu, Xiao-Ning
Autoantibody-dependent amplification of inflammation in SLE
title Autoantibody-dependent amplification of inflammation in SLE
title_full Autoantibody-dependent amplification of inflammation in SLE
title_fullStr Autoantibody-dependent amplification of inflammation in SLE
title_full_unstemmed Autoantibody-dependent amplification of inflammation in SLE
title_short Autoantibody-dependent amplification of inflammation in SLE
title_sort autoantibody-dependent amplification of inflammation in sle
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481301/
https://www.ncbi.nlm.nih.gov/pubmed/32908129
http://dx.doi.org/10.1038/s41419-020-02928-6
work_keys_str_mv AT louhantao autoantibodydependentamplificationofinflammationinsle
AT wojciakstothardbeata autoantibodydependentamplificationofinflammationinsle
AT rusevamarietam autoantibodydependentamplificationofinflammationinsle
AT cookhterence autoantibodydependentamplificationofinflammationinsle
AT kelleherpeter autoantibodydependentamplificationofinflammationinsle
AT pickeringmatthewc autoantibodydependentamplificationofinflammationinsle
AT mongkolsapayajuthathip autoantibodydependentamplificationofinflammationinsle
AT screatongavinr autoantibodydependentamplificationofinflammationinsle
AT xuxiaoning autoantibodydependentamplificationofinflammationinsle